Home > Healthcare > Medical Devices > Diagnostic Devices > Newborn Screening Market

Newborn Screening Market Trends

Report ID: GMI8223
Published Date: Feb 2024
Report Format: PDF

Download Free Sample

Newborn Screening Market Trends

With companies increasingly launching advanced devices to improve early detection of genetic disorders in infants, the market is set to witness steady growth. These innovative screening tools are enhancing diagnostic accuracy and accessibility. The ongoing technological advancements are making way for the rising awareness among healthcare providers and parents.

The continuous development of more efficient and reliable screening solutions are ensuring better health outcomes for newborns worldwide. This innovation will transform newborn screening practices for making early detection and intervention more effective and widespread. For instance, in September 2023, Mylab launched MyNeoShield, a point-of-care newborn screening device for revolutionizing newborn healthcare by providing faster, more accessible, and cost-effective screening for saving lives and preventing lifelong illnesses through early detection and intervention.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Newborn screening market size was USD 950.5 million in 2023 and is expected to register 7.7% CAGR from 2024-2032 owing to the rising incidence of genetic and metabolic diseases and growing burden of congenital disorders worldwide.

Newborn screening industry from the instruments segment is expected to register 7.8% CAGR from 2024-2032 due to clinics increasingly employing sophisticated instruments for newborn screening to detect metabolic and genetic disorders early.

North America newborn screening industry is expected to record over USD 837 million by 2032 due to increasing advancements in diagnostic techniques and the expansion of screening panels in the region.

Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., GE Healthcare, Masimo Corporation, Medtronic plc, Natus Medical Incorporated, PerkinElmer, Inc., Thermo Fisher Scientific Inc., Trivitron Healthcare, and Waters Corporation, are some of the major newborn screening companies worldwide.